Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02845180 · ClinicalTrials.gov registry record · NA
In-Vivo Assessment of Adipose Allograft Extracellular Matrix in Abdominoplasty Patients
A NA study, sponsored by Musculoskeletal Transplant Foundation.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02845180 is a NA study that has completed, run by Musculoskeletal Transplant Foundation. The registered enrollment target is 10 participants.
The verdict
NCT02845180, a NA study, has completed, sponsored by Musculoskeletal Transplant Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to assess local tissue reaction and retention of an adipose allograft extracellular matrix at 3 or 6 months post-injection into the subcutaneous abdominal tissue of healthy volunteers scheduled to undergo elective panniculectomy.
Interventions
- PROCEDURE Adipose Allograft Extracellular Matrix (AAM) Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-11 |
| Est. Completion | 2018-06-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02845180
The ClinicalTrials.gov registry entry for NCT02845180 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Musculoskeletal Transplant Foundation, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Adipose Allograft Extracellular Matrix (AAM) Injection is the first listed.
NCT02845180 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02845180 about?
NCT02845180 is a clinical study titled "In-Vivo Assessment of Adipose Allograft Extracellular Matrix in Abdominoplasty Patients". The purpose of this study is to assess local tissue reaction and retention of an adipose allograft extracellular matrix at 3 or 6 months post-injection into the subcutaneous abdominal tissue of healthy volunteers scheduled to undergo elective panniculectomy.
What is the current status of trial NCT02845180?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2016-11. Estimated completion is 2018-06-15.
What interventions are being tested in trial NCT02845180?
The interventions under investigation include: Adipose Allograft Extracellular Matrix (AAM) Injection (PROCEDURE).
Who is sponsoring clinical trial NCT02845180?
This trial is sponsored by Musculoskeletal Transplant Foundation, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.